Study for genetic susceptibility to pancreatic cancer
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000016984
- Lead Sponsor
- Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Cases with neuroendocrine tumor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whole-exome sequencing using genomic DNA isolated from saliva, blood and the tissue
- Secondary Outcome Measures
Name Time Method Histopathological analysis and somatic mutation, gene expression and methylation analysis using the resected specimens
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic polymorphisms are associated with increased susceptibility to pancreatic cancer in the JPRN-UMIN000016984 observational study?
Which biomarkers identified in JPRN-UMIN000016984 correlate with early detection or prognosis of pancreatic cancer?
How do heritable risk factors from JPRN-UMIN000016984 compare to environmental contributors in pancreatic cancer pathogenesis?
What molecular targets for pancreatic cancer therapy were identified in the Sapporo Higashi Tokushukai Hospital genetic susceptibility study?
What adverse outcomes are linked to specific genetic profiles in JPRN-UMIN000016984's 100-participant pancreatic cancer cohort?